Mayer B. Davidson, MD
Title Professor
Institution Charles R. Drew University of Medicine and Science
Department Internal Medicine
School College of Medicine
Address 1731 E. 120th Street, Hawkins Building


Telephone (323) 357-3439
Fax
Email
Education & Training
Teaching
NIH Awarded Grants
Publications
1. Davidson MB. The "Cost-Effective" Beneficial Effect of Pioglitazone on Cardiovascular Disease. Diabetes Res Clin Pract. 2020 May 27; 108223.
  View in: PubMed
 
2. Davidson MB. Second-generation basal insulins to initiate insulin therapy in type 2 diabetes: A need for clinical evidence before incurring increased costs. Diabetes Obes Metab. 2020 May; 22(5):719-721.
  View in: PubMed
 
3. Davidson MB. SGLT-2 inhibitors were not linked to severe or nonsevere UTIs vs DPP-4 inhibitors or GLP-1 agonists. Ann Intern Med. 2019 12 17; 171(12):JC70.
  View in: PubMed
 
4. Hsia SH, Duran P, Lee ML, Davidson MB. Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study. J Diabetes. 2020 Jan; 12(1):91-94.
  View in: PubMed
 
5. Davidson MB. The Case for Using Human Insulin. Am J Med. 2020 02; 133(2):e23-e24.
  View in: PubMed
 
6. Davidson MB. Response to Umpierrez et al. Diabetes Obes Metab. 2019 10; 21(10):2344-2345.
  View in: PubMed
 
7. Davidson MB. Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes. Ann Intern Med. 2019 04 16; 170(8):JC39.
  View in: PubMed
 
8. Davidson MB. Delayed response to an injection of U-500 regular insulin is not rare. J Diabetes. 2019 Jul; 11(7):519-521.
  View in: PubMed
 
9. Davidson MB, Davidson SJ. Effect of Remote Glucose Monitoring Utilizing Computerized Insulin Dose Adjustment Algorithms: A Pilot Project. Diabetes Ther. 2019 Apr; 10(2):523-533.
  View in: PubMed
 
10. Davidson MB, Pan D. Corrigendum to "An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis" [Diab. Res. Clin. Pract. 135 (2018) 102-110]. Diabetes Res Clin Pract. 2018 08; 142:408-409.
  View in: PubMed
 
11. Davidson MB. Erratum: Delayed Response to U-500 Regular Insulin. Clinical Diabetes 2018;36: 77-79 (DOI: 10.2337/cd16-0058). Clin Diabetes. 2018 04; 36(2):208.
  View in: PubMed
 
12. Davidson MB, Duran P, Davidson SJ, Lee M. Comparison of Insulin Dose Adjustments by Primary Care Physicians and Endocrinologists. Clin Diabetes. 2018 Jan; 36(1):39-43.
  View in: PubMed
 
13. Davidson MB. Delayed Response to U-500 Regular Insulin. Clin Diabetes. 2018 Jan; 36(1):77-79.
  View in: PubMed
 
14. Davidson MB, Pan D. An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. Diabetes Res Clin Pract. 2018 Jan; 135:102-110.
  View in: PubMed
 
15. Zgibor JC, Maloney MA, Malmi M, Fabio A, Kuo S, Solano FX, Tilves D, Tu L, Davidson MB. Effectiveness of certified diabetes educators following pre-approved protocols to redesign diabetes care delivery in primary care: Results of the REMEDIES 4D trial. Contemp Clin Trials. 2018 01; 64:201-209.
  View in: PubMed
 
16. Davidson MB. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Taking Insulin Injections. JAMA. 2017 01 24; 317(4):363-364.
  View in: PubMed
 
17. Davidson MB. Diabetic retinopathy is not present in non-diabetic older overweight/obese African Americans. Diabetes Res Clin Pract. 2017 04; 126:322.
  View in: PubMed
 
18. Davidson MB. Diabetic retinopathy is not present in newly diagnosed diabetic patients. Diabetologia. 2016 12; 59(12):2727.
  View in: PubMed
 
19. Davidson MB, Kahn RA. A Reappraisal of Prediabetes. J Clin Endocrinol Metab. 2016 07; 101(7):2628-35.
  View in: PubMed
 
20. Davidson MB. Pioglitazone (Actos) and bladder cancer: Legal system triumphs over the evidence. J Diabetes Complications. 2016 08; 30(6):981-5.
  View in: PubMed
 
21. Davidson MB. Insulin Therapy: A Personal Approach. Clin Diabetes. 2015 Jul; 33(3):123-35.
  View in: PubMed
 
22. Kahn R, Davidson MB. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes Care 2014;37:943-949. Diabetes Care. 2014 Dec; 37(12):e276-7.
  View in: PubMed
 
23. Davidson MB. Response to comment on Grunberger "insulin analogs-are they worth it? Yes!" Diabetes Care 2014;37:1767-1770 and Davidson "insulin analogs-is there a compelling case to use them? No!" Diabetes Care 2014;37:1771-1774. Diabetes Care. 2014 Oct; 37(10):e231.
  View in: PubMed
 
24. Kahn R, Davidson MB. Response to comment on Kahn and Davidson. The reality of type 2 diabetes prevention. Diabetes care 2014;37:943-949. Diabetes Care. 2014 Aug; 37(8):e187.
  View in: PubMed
 
25. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA. Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct; 99(10):3551-60.
  View in: PubMed
 
26. Zgibor JC, Kuo S, Emerson S, Gittinger P, Solano FX, Tilves D, Maloney M, Davidson MB. Rationale, design, and implementation of a cluster randomized trial using certified diabetes educators to intensify treatment for glycemia, blood pressure and lipid control: REMEDIES 4D. Contemp Clin Trials. 2014 Sep; 39(1):124-31.
  View in: PubMed
 
27. Davidson MB. Insulin analogs--is there a compelling case to use them? No! Diabetes Care. 2014 Jun; 37(6):1771-4.
  View in: PubMed
 
28. Davidson MB, Pan D. Epidemiological ramifications of diagnosing diabetes with HbA1c levels. J Diabetes Complications. 2014 Jul-Aug; 28(4):464-9.
  View in: PubMed
 
29. Kahn R, Davidson MB. The reality of type 2 diabetes prevention. Diabetes Care. 2014 Apr; 37(4):943-9.
  View in: PubMed
 
30. Davidson MB, Duran P, Lee ML. Community screening for pre-diabetes and diabetes using HbA1c levels in high-risk African Americans and Latinos. Ethn Dis. 2014; 24(2):195-9.
  View in: PubMed
 
31. Davidson MB. Self-mixed/split insulin regimen: a serious omission in the ADA/EASD position statement. Diabetes Care. 2014; 37(1):3-4.
  View in: PubMed
 
32. Davidson MB. Response to comment on: Davidson et al. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care 2013;36:260-266. Diabetes Care. 2013 May; 36(5):e72.
  View in: PubMed
 
33. Davidson MB. Comment on: Tam et al. Defining insulin resistance from hyperinsulinemic-euglycemic clamps. Diabetes Care 2012;35:1605-1610. Diabetes Care. 2013 Jan; 36(1):e10.
  View in: PubMed
 
34. Davidson MB, Duran P, Lee ML, Friedman TC. High-dose vitamin D supplementation in people with prediabetes and hypovitaminosis D. Diabetes Care. 2013 Feb; 36(2):260-6.
  View in: PubMed
 
35. Shimizu T, Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. [Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes]. Nihon Rinsho. 2012 May; 70 Suppl 3:591-601.
  View in: PubMed
 
36. Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, Davidson MB, Guerci B, Coates V, Schwedes U, O'Malley S. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012 Feb 27; 344:e486.
  View in: PubMed
 
37. Toscos TR, Ponder SW, Anderson BJ, Davidson MB, Lee ML, Montemayor-Gonzalez E, Reyes P, Link E, McMahon KL. Integrating an Automated Diabetes Management System into the family management of children with type 1 diabetes: results from a 12-month randomized controlled technology trial. Diabetes Care. 2012 Mar; 35(3):498-502.
  View in: PubMed
 
38. Davidson MB. Comment on: Hellemons et al. Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial. Diabetes Care 2011;34:2078-2083. Diabetes Care. 2011 Dec; 34(12):e188.
  View in: PubMed
 
39. Hsia SH, Navar MD, Duran P, Shaheen M, Davidson MB. Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus. Endocr Pract. 2011 Sep-Oct; 17(5):691-8.
  View in: PubMed
 
40. Davidson MB, Raskin P, Tanenberg RJ, Vlajnic A, Hollander P. A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure. Endocr Pract. 2011 May-Jun; 17(3):395-403.
  View in: PubMed
 
41. Davidson MB, Echeverry D. Collaborative care for depression and chronic illnesses. N Engl J Med. 2011 03 31; 364(13):1278; author reply 1278-9.
  View in: PubMed
 
42. Davidson MB. Diagnosing diabetes with glucose criteria: worshiping a false God. Diabetes Care. 2011 Feb; 34(2):524-6.
  View in: PubMed
 
43. Davidson MB. Evaluation of self monitoring of blood glucose in non-insulin-treated diabetic patients by randomized controlled trials: little bang for the buck. Rev Recent Clin Trials. 2010 Sep; 5(3):138-42.
  View in: PubMed
 
44. Davidson MB, Blanco-Castellanos M, Duran P. Integrating nurse-directed diabetes management into a primary care setting. Am J Manag Care. 2010 Sep; 16(9):652-6.
  View in: PubMed
 
45. Davidson MB. Counterpoint: postprandial glucose levels are not a clinically important treatment target. Diabetes Care. 2010 Aug; 33(8):1908-10.
  View in: PubMed
 
46. Davidson MB. Daily self-monitoring unlikely to be cost-effective in adults with type 2 diabetes not using insulin in Canada. Evid Based Med. 2010 Jun; 15(3):75-6.
  View in: PubMed
 
47. Davidson MB. Correction to the 2010 report on the diagnosis and classification of diabetes. Diabetes Care. 2010 Apr; 33(4):e57.
  View in: PubMed
 
48. Davidson MB, Schriger DL. Effect of age and race/ethnicity on HbA1c levels in people without known diabetes mellitus: implications for the diagnosis of diabetes. Diabetes Res Clin Pract. 2010 Mar; 87(3):415-21.
  View in: PubMed
 
49. Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
  View in: PubMed
 
50. Echeverry D, Duran P, Bonds C, Lee M, Davidson MB. Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial. Diabetes Care. 2009 Dec; 32(12):2156-60.
  View in: PubMed
 
51. Davidson MB. Novel noninvasive breath test method for screening individuals at risk for diabetes: response to Dillon et al. Diabetes Care. 2009 Jul; 32(7):e88; author reply e89.
  View in: PubMed
 
52. Davidson MB. Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation. Curr Opin Endocrinol Diabetes Obes. 2009 Apr; 16(2):107-12.
  View in: PubMed
 
53. Davidson MB. How our current medical care system fails people with diabetes: lack of timely, appropriate clinical decisions. Diabetes Care. 2009 Feb; 32(2):370-2.
  View in: PubMed
 
54. Davidson MB. Detailed treatment algorithms for effective nurse- and pharmacist-directed diabetes care: a personal approach. Diabetes Educ. 2009 Jan-Feb; 35(1):61-71.
  View in: PubMed
 
55. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009 Jan; 32(1):193-203.
  View in: PubMed
 
56. Davidson MB. No need for the needle (at first). Diabetes Care. 2008 Oct; 31(10):2070-1.
  View in: PubMed
 
57. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008 Jul; 93(7):2447-53.
  View in: PubMed
 
58. Davidson MB, Ramos L. Metformin does not suppress thyrotropin. Endocr Pract. 2008 Mar; 14(2):252-3.
  View in: PubMed
 
59. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2008 Jan; 31(1):173-5.
  View in: PubMed
 
60. Davidson MB. The effectiveness of nurse- and pharmacist-directed care in diabetes disease management: a narrative review. Curr Diabetes Rev. 2007 Nov; 3(4):280-6.
  View in: PubMed
 
61. Ogunyemi D, Jesse M, Davidson M. Comparison of glyburide versus insulin in management of gestational diabetes mellitus. Endocr Pract. 2007 Jul-Aug; 13(4):427-8.
  View in: PubMed
 
62. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999 2004 NHANES population. Diabetes Care. 2007 Sep; 30(9):2233-5.
  View in: PubMed
 
63. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, Zinman B. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007 Mar; 30(3):753-9.
  View in: PubMed
 
64. Davidson MB, Ansari A, Karlan VJ. Effect of a nurse-directed diabetes disease management program on urgent care/emergency room visits and hospitalizations in a minority population. Diabetes Care. 2007 Feb; 30(2):224-7.
  View in: PubMed
 
65. Davidson MB. Clinical implications of the DREAM Study. Diabetes Care. 2007 Feb; 30(2):418-20.
  View in: PubMed
 
66. Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
  View in: PubMed
 
67. Davidson MB. Does the metabolic syndrome exist: response to Grundy. Diabetes Care. 2006 Nov; 29(11):2565; author reply 2565-6.
  View in: PubMed
 
68. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B. Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2006 Aug; 29(8):1963-72.
  View in: PubMed
 
69. Tran MT, Navar MD, Davidson MB. Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes. Diabetes Care. 2006 Jun; 29(6):1395-6.
  View in: PubMed
 
70. Davidson MB, Castellanos M, Duran P, Karlan V. Effective diabetes care by a registered nurse following treatment algorithms in a minority population. Am J Manag Care. 2006 Apr; 12(4):226-32.
  View in: PubMed
 
71. Davidson MB. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2006 Mar; 29(3):745; author reply 746.
  View in: PubMed
 
72. Echeverry D, Dike M, Jovanovic L, Wollitzer AO, Westphal S, Mudaliar S, Washington C, Davidson MB. Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event. Am J Manag Care. 2005 Dec; 11(12):758-64.
  View in: PubMed
 
73. Davidson MB. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: response to Welschen et al. and Kleefstra et al. Diabetes Care. 2005 Oct; 28(10):2597; author reply 2597-8.
  View in: PubMed
 
74. Davidson MB. The effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care. Am J Manag Care. 2005 Sep; 11(9):585; author reply 585.
  View in: PubMed
 
75. Davidson MB, Bate G, Kirkpatrick P. Exenatide. Nat Rev Drug Discov. 2005 Sep; 4(9):713-4.
  View in: PubMed
 
76. Davidson MB. Counterpoint: Self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005 Jun; 28(6):1531-3.
  View in: PubMed
 
77. Davidson MB. SF-36 and diabetes outcome measures. Diabetes Care. 2005 Jun; 28(6):1536-7.
  View in: PubMed
 
78. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005 Apr; 118(4):422-5.
  View in: PubMed
 
79. Davidson MB. Starting insulin therapy in type 2 diabetic patients: does it really matter how? Diabetes Care. 2005 Feb; 28(2):494-5.
  View in: PubMed
 
80. Davidson MB. Glycemia and risk for cardiovascular disease. Ann Intern Med. 2005 Feb 01; 142(3):227; author reply 227-8.
  View in: PubMed
 
81. Davidson MB. Thiazolidinediones. N Engl J Med. 2005 Jan 13; 352(2):205-7; author reply 205-7.
  View in: PubMed
 
82. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. Using focus groups of older African Americans and Latinos with diabetes to modify a self-care empowerment intervention. Ethn Dis. 2005; 15(2):283-91.
  View in: PubMed
 
83. Sarkisian CA, Brusuelas RJ, Steers WN, Davidson MB, Brown AF, Norris KC, Anderson RM, Mangione CM. For the patient. Managing diabetes with cultural sensitivity and self-empowerment. Ethn Dis. 2005; 15(2):351.
  View in: PubMed
 
84. Davidson MB. Early insulin therapy for type 2 diabetic patients: more cost than benefit. Diabetes Care. 2005 Jan; 28(1):222-4.
  View in: PubMed
 
85. Davidson MB, Dulan S, Duran P, Bazargan M. Indirect support for the use of supplemental insulin in hospitalized insulin-requiring diabetic patients. Diabetes Care. 2004 Sep; 27(9):2260-1.
  View in: PubMed
 
86. Hsia SH, Bazargan M, Davidson MB. Effect of Pancreas Tonic (an ayurvedic herbal supplement) in type 2 diabetes mellitus. Metabolism. 2004 Sep; 53(9):1166-73.
  View in: PubMed
 
87. Roy R, Navar M, Palomeno G, Davidson MB. Real world effectiveness of rosiglitazone added to maximal (tolerated) doses of metformin and a sulfonylurea agent: a systematic evaluation of triple oral therapy in a minority population. Diabetes Care. 2004 Jul; 27(7):1741-2.
  View in: PubMed
 
88. Davidson MB. Triple therapy: definitions, application, and treating to target. Diabetes Care. 2004 Jul; 27(7):1834-5.
  View in: PubMed
 
89. Davidson MB. Twice-Daily NPH or mixture insulins versus triple therapy: apples versus oranges: response to Poulsen et al. Diabetes Care. 2004 Jul; 27(7):1846; author reply 1847-8.
  View in: PubMed
 
90. Davidson MB. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection. Diabetes Res Clin Pract. 2004 Jun; 64(3):229.
  View in: PubMed
 
91. Davidson MB. Status of research funding by the American Diabetes Association--5th and final year. Diabetes. 2004 May; 53(5):1403.
  View in: PubMed
 
92. Davidson MB. Status of research funding by the American Diabetes Association--5th and final year. Diabetes Care. 2004 May; 27(5):1235.
  View in: PubMed
 
93. Davidson MB, Bazargan M, Bakris G, Peters Harmel A, Campese V, Basta E. ImmunoDip: an improved screening method for microalbuminuria. Am J Nephrol. 2004 May-Jun; 24(3):284-8.
  View in: PubMed
 
94. Davidson MB. More evidence to support "outsourcing" of diabetes care. Diabetes Care. 2004 Apr; 27(4):995.
  View in: PubMed
 
95. Davidson MB. Novel risk factors for atherosclerosis. JAMA. 2004 Jan 21; 291(3):301; author reply 301-2.
  View in: PubMed
 
96. Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003 Dec; 26(12):3329-30.
  View in: PubMed
 
97. Echeverry DM, Dike MR, Washington C, Davidson MB. The impact of using a low-literacy patient education tool on process measures of diabetes care in a minority population. J Natl Med Assoc. 2003 Nov; 95(11):1074-81.
  View in: PubMed
 
98. Davidson MB. Metabolic syndrome/insulin resistance syndrome/pre-diabetes: new section in diabetes care. Diabetes Care. 2003 Nov; 26(11):3179.
  View in: PubMed
 
99. Davidson MB. Is treatment of insulin resistance beneficial independent of glycemia? Diabetes Care. 2003 Nov; 26(11):3184-6.
  View in: PubMed
 
100. Davidson MB. Effect of nurse-directed diabetes care in a minority population. Diabetes Care. 2003 Aug; 26(8):2281-7.
  View in: PubMed
 
Funding Opportunities

Click terms below for current NIH/NSF funding opportunities.
  • Diabetes Mellitus, Type 2


  • Hypoglycemic Agents


  • Diabetes Mellitus


  • Insulin


  • Glycated Hemoglobin A


Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile:
 
Keyword
Last Name
Institution
Department
School
    
 
 
 
Keywords   
Diabetes Mellitus, Type 2
Hypoglycemic Agents
Diabetes Mellitus
Insulin
Glycated Hemoglobin A
See all (225) keywords
Co-Authors  
Bonds, Curley
Friedman, Theodore
Hsia, Stanley
Lee, Martin
Pan, Deyu
See all (6) people
Physical Neighbors  
Sinha-Hikim, Amiya
Pervin, Shehla
Hsia, Stanley
Friedman, Theodore
Rajavashisth, Tripathi


© Charles Drew University of Medicine And Science - Accelerating Excellence In Translational Science (AXIS), All rights reserved.